Parkin and α-synuclein:: Opponent actions in the pathogenesis of Parkinson's disease

被引:7
|
作者
Baptista, MJ [1 ]
Cookson, MR [1 ]
Miller, DW [1 ]
机构
[1] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA
关键词
Lewy bodies; mitochondria; parkin; proteasome; synapses; synuclein;
D O I
10.1177/1073858403260392
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Dominant mutations in the gene for alpha-synuclein, a small presynaptic protein, can cause Parkinson's disease. Although there is still substantial debate about the precise mechanisms, alpha-synuclein is toxic to vulnerable neurons, probably as a result of its tendency to aggregate. Opposing this is another gene product that, when mutated, causes a recessive form of parkinsonism, parkin. Parkin has been recently shown to protect cells against alpha-synuclein toxicity. However, the precise details of the mechanism are unclear. This review will discuss the concept that there are multiple neuronal functions that are targeted by mutant alpha-synuclein, and in many cases, there is evidence that parkin can protect cells against damage to the same systems. The authors will also discuss ways in which to test some of these ideas, by using newly identified genes such as DJ-1 that cause similar phenotypes.
引用
收藏
页码:63 / 72
页数:10
相关论文
共 50 条
  • [31] Can parkin be a target for future treatment of Parkinson's disease?
    Kubo, Shin-ichiro
    Hatano, Taku
    Takanashi, Masashi
    Hattori, Nobutaka
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (10) : 1133 - 1144
  • [32] Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
    Pozo Devoto, Victorio M.
    Falzone, Tomas L.
    DISEASE MODELS & MECHANISMS, 2017, 10 (09) : 1075 - 1087
  • [33] Neuropathology of α-synuclein in Parkinson's disease
    Choong, Chi-Jing
    Mochizuki, Hideki
    NEUROPATHOLOGY, 2022, 42 (02) : 93 - 103
  • [34] Phosphorylated α-Synuclein in Parkinson's Disease
    Wang, Yu
    Shi, Min
    Chung, Kathryn A.
    Zabetian, Cyrus P.
    Leverenz, James B.
    Berg, Daniela
    Srulijes, Karin
    Trojanowski, John Q.
    Lee, Virginia M. -Y.
    Siderowf, Andrew D.
    Hurtig, Howard
    Litvan, Irene
    Schiess, Mya C.
    Peskind, Elaine R.
    Masuda, Masami
    Hasegawa, Masato
    Lin, Xiangmin
    Pan, Catherine
    Galasko, Douglas
    Goldstein, David S.
    Jensen, Poul Henning
    Yang, Hui
    Cain, Kevin C.
    Zhang, Jing
    SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (121)
  • [35] Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis
    Alberio, Tiziana
    Bossi, Alessandra Maria
    Milli, Alberto
    Parma, Elisa
    Gariboldi, Marzia Bruna
    Tosi, Giovanna
    Lopiano, Leonardo
    Fasano, Mauro
    FEBS JOURNAL, 2010, 277 (23) : 4909 - 4919
  • [36] Ubiquitin-protein ligase parkin and its role in the development of Parkinson’s disease
    O. A. Buneeva
    A. E. Medvedev
    Biochemistry (Moscow), 2006, 71 : 851 - 860
  • [37] Ubiquitin-protein ligase parkin and its role in the development of Parkinson's disease
    Buneeva, O. A.
    Medvedev, A. E.
    BIOCHEMISTRY-MOSCOW, 2006, 71 (08) : 851 - 860
  • [38] Neuronal vulnerability, pathogenesis, and Parkinson's disease
    Sulzer, David
    Surmeier, D. James
    MOVEMENT DISORDERS, 2013, 28 (06) : 715 - 724
  • [39] Genetic and molecular pathogenesis of Parkinson's disease
    Agorogiannis, E. I.
    Agorogiannis, G. I.
    Papadimitriou, A.
    Hadjigeorgiou, G. M.
    ARCHIVES OF HELLENIC MEDICINE, 2006, 23 (05): : 435 - 443
  • [40] Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson's Disease Etiopathology
    Wilkaniec, Anna
    Lenkiewicz, Anna M.
    Czapski, Grzegorz A.
    Jesko, Henryk M.
    Hilgier, Wojciech
    Brodzik, Robert
    Gassowska-Dobrowolska, Magdalena
    Culmsee, Carsten
    Adamczyk, Agata
    MOLECULAR NEUROBIOLOGY, 2019, 56 (01) : 125 - 140